<?xml version="1.0" encoding="UTF-8"?>
<ref id="B52-ijms-19-01312">
 <label>52.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Petrou</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Gothelf</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Argov</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Gotkine</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Levy</surname>
    <given-names>Y.S.</given-names>
   </name>
   <name>
    <surname>Kassis</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Vaknin-Dembinsky</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Ben-Hur</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Offen</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Abramsky</surname>
    <given-names>O.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Safety and clinical effects of mesenchymal stem cells secreting neurotrophic factor transplantation in patients with amyotrophic lateral sclerosis: Results of phase 1/2 and 2a clinical trials</article-title>
  <source>JAMA Neurol.</source>
  <year>2016</year>
  <volume>73</volume>
  <fpage>337</fpage>
  <lpage>344</lpage>
  <pub-id pub-id-type="doi">10.1001/jamaneurol.2015.4321</pub-id>
  <?supplied-pmid 26751635?>
  <pub-id pub-id-type="pmid">26751635</pub-id>
 </element-citation>
</ref>
